A collaborative study published on January 21 in Nature Communications presents a novel strategy to improve the effectiveness ...

A collaborative study, published on January 21 on Nature Communications, presents a novel strategy to improve the ...

A 58-year-old male patient presented to the dermatology clinic at West China Hospital of Sichuan University (Chengdu, Sichuan ...

This epithelium is present not only in the eye, mouth, and genitalia but also in the nasopharynx. Although various lesions on the external nose are well known, those within it are not. Patients ...

Transferrin receptor 1 (TfR1) has been shown to be upregulated in nasopharyngeal carcinoma (NPC). Here the authors report that TfR1 can be targeted in hypoxic NPC lesions using ferritin nanozymes.

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...

Transferrin receptor 1 (TfR1) has been shown to be upregulated in nasopharyngeal carcinoma (NPC). Here the authors report that TfR1 can be targeted in hypoxic NPC lesions using ferritin nanozymes.

Lesions may affect the face, ears, and scalp, but the palms and soles are rarely involved. Other findings may include evidence of pharyngeal or perianal erythema secondary to a concurrent ...

For the small area of skin lesion (GP), we swabbed multiple skin lesions with a sterile cotton swab. To collect the pharyngeal samples, an oropharyngeal swab was taken by swabbing and twirling the ...

Nasopharyngeal carcinoma (NPC ... might provide more information of the lesion thus assisting in decision making during clinical practice, such as chemotherapy and/or immunotherapy management or ...

Researchers have developed a novel experimental platform to measure the electric fields of light trapped between two mirrors ...